Carbidopa and Levodopa Sustained-Release Tablets

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For oral administration
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
Gold Member Since 2018

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Management System Certification
ISO 9001, ISO 14001, GMP
  • Carbidopa and Levodopa Sustained-Release Tablets
  • Carbidopa and Levodopa Sustained-Release Tablets
  • Carbidopa and Levodopa Sustained-Release Tablets
  • Carbidopa and Levodopa Sustained-Release Tablets
  • Carbidopa and Levodopa Sustained-Release Tablets
  • Carbidopa and Levodopa Sustained-Release Tablets
Find Similar Products

Basic Info.

Model NO.
50mg+200mg
State
Solid
Shape
Tablet
Type
Inorganic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Transport Package
Carton
Specification
50mg+200mg
Trademark
SHIMEN
Origin
China
HS Code
3004909099
Production Capacity
1000000

Product Description

Carbidopa and Levodopa Sustained-release Tablet
 
Name: Carbidopa and Levodopa Sustained-release Tablet

Description The product is slightly pink, mixed slight yellow oval tablet.
Indication
Used for Parkinson's disease.


Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.
Carbidopa and Levodopa Sustained-Release Tablets
Carbidopa and Levodopa Sustained-Release Tablets

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier